RadNet Inc

Post-Capitulation exhaustion at the flush low has established a mean-reversion foundation. Small overlapping candles with long lower wicks hold above the April lows, and RSI remains flat near oversold. Price is pulling back into declining 9/21/50 EMAs without clear acceptance or rejection. Medium-term bias is bullish under mean-reversion permission, but short-term timing is neutral; we will stalk deferred buy into the EMA support zone pending a clean resolution.

• ↑Q2 revenue $622.7M (+25% YoY) and adjusted EPS $0.29 beat estimates.
• ↑Digital Health sales grew 56.5% to $32.4M; ARR jumped to $105.5M.
• ↓GAAP net income fell to $7.5M from $14.5M, pressuring margins.